Literature DB >> 27457347

Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment.

Ludovico Abenavoli1, Mario Masarone, Alessandro Federico, Valerio Rosato, Marcello Dallio, Carmela Loguercio, Marcello Persico.   

Abstract

Alcohol represents the oldest substance of abuse known and Alcoholic Liver Disease (ALD) is the most common cause of chronic liver disease worldwide. The ALD includes a wide spectrum of injury and may lead progressively from simple steatosis to frank cirrhosis. The ALD diagnosis may be hard and it is mainly defined by the history of chronic alcohol intake, physical and laboratory abnormalities suggestive of liver disease. Abstinence is the cornerstone of ALD therapy. Although the burden on health of ALD is not negligible, in the last decades few therapeutic advances have been made. Because of the complex pathogenetic mechanisms, the therapy of ALD and especially of severe Alcoholic Hepatitis (AH), represents a thorny problem in the clinical practice. In severe forms of acute AH, some specific drug treatments, including glucorticoids or pentoxifylline, have been defined and are, at the moment, recommended by international guidelines. On the contrary, specific long-term treatments of ALD, aimed at stopping the progression of fibrosis, are not yet approved.

Entities:  

Mesh:

Year:  2016        PMID: 27457347     DOI: 10.2174/1574887111666160724183409

Source DB:  PubMed          Journal:  Rev Recent Clin Trials        ISSN: 1574-8871


  5 in total

1.  Aqueous Mulberry Leaf Extract Ameliorates Alcoholic Liver Injury Associating with Upregulation of Ethanol Metabolism and Suppression of Hepatic Lipogenesis.

Authors:  Yi-Ju Lee; Ming-Chang Tsai; Hui-Ting Lin; Chau-Jong Wang; Shao-Hsuan Kao
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-08       Impact factor: 2.629

2.  Nutrition and Liver Disease.

Authors:  Claudia Mandato; Antonella Di Nuzzi; Pietro Vajro
Journal:  Nutrients       Date:  2017-12-23       Impact factor: 5.717

3.  A Survey of Molecular Heterogeneity in Hepatocellular Carcinoma.

Authors:  Juan Jovel; Zhen Lin; Sandra O'keefe; Steven Willows; Weiwei Wang; Guangzhi Zhang; Jordan Patterson; Carlos Moctezuma-Velázquez; David J Kelvin; Gane Ka-Shu Wong; Andrew L Mason
Journal:  Hepatol Commun       Date:  2018-07-12

4.  Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease.

Authors:  Moris Sangineto; Christoph Grander; Felix Grabherr; Lisa Mayr; Barbara Enrich; Julian Schwärzler; Marcello Dallio; Vidyasagar Naik Bukke; Archana Moola; Antonio Moschetta; Timon E Adolph; Carlo Sabbà; Gaetano Serviddio; Herbert Tilg
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 5.  The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis.

Authors:  Hyeong Geug Kim; Jung-Hyo Cho; Jeongkyu Kim; Seung-Jin Kim
Journal:  Front Physiol       Date:  2021-07-16       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.